Skip to content
10-Q

Quarterly Report

Axogen, Inc. AXGN

0000805928-26-000053

← back to feed
Filed
Apr 28, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 24, 2026 53.18M sh
Shares Diluted Q1 2026 · Mar 31, 2026 51.59M sh
Shares Diluted Q1 2026 · Mar 31, 2025 45.2M sh
Capex Q1 2026 · Mar 31, 2026 $2.79M
Capex Q1 2026 · Mar 31, 2025 $256K
Operating Cash Flow Q1 2026 · Mar 31, 2026 $1.57M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$13.18M
Long Term Debt Q1 2026 · Mar 31, 2026 $0
Long Term Debt Q1 2026 · Dec 31, 2025 $48.39M
Short Term Investments Q1 2026 · Mar 31, 2026 $18.95M
Short Term Investments Q1 2026 · Dec 31, 2025 $5.98M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $82.65M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $35.55M
Stockholders Equity Q1 2026 · Mar 31, 2026 $244.81M
Stockholders Equity Q1 2026 · Dec 31, 2025 $128.85M
Stockholders Equity Q1 2026 · Mar 31, 2025 $105.37M
Stockholders Equity Q1 2026 · Dec 31, 2024 $103.91M
Current Liabilities Q1 2026 · Mar 31, 2026 $26.01M
Current Liabilities Q1 2026 · Dec 31, 2025 $23.56M
Total Liabilities Q1 2026 · Mar 31, 2026 $44.68M
Total Liabilities Q1 2026 · Dec 31, 2025 $92.84M
Current Assets Q1 2026 · Mar 31, 2026 $184.71M
Current Assets Q1 2026 · Dec 31, 2025 $120.42M
Total Assets Q1 2026 · Mar 31, 2026 $289.49M
Total Assets Q1 2026 · Dec 31, 2025 $221.69M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.38
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.08
Eps Basic Q1 2026 · Mar 31, 2026 −$0.38
Eps Basic Q1 2026 · Mar 31, 2025 −$0.08
Sga Expense Q1 2026 · Mar 31, 2026 $12.87M
Sga Expense Q1 2026 · Mar 31, 2025 $9.46M
Rd Expense Q1 2026 · Mar 31, 2026 $7.52M
Rd Expense Q1 2026 · Mar 31, 2025 $6.09M
Net Income Q1 2026 · Mar 31, 2026 −$19.58M
Net Income Q1 2026 · Mar 31, 2025 −$3.83M
Operating Income Q1 2026 · Mar 31, 2026 −$2.83M
Operating Income Q1 2026 · Mar 31, 2025 −$1.66M
Gross Profit Q1 2026 · Mar 31, 2026 $46.19M
Gross Profit Q1 2026 · Mar 31, 2025 $34.93M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $15.27M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $13.63M
Revenue Q1 2026 · Mar 31, 2026 $61.46M
Revenue Q1 2026 · Mar 31, 2025 $48.56M